Brief: Targovax And Papyrus Therapeutics Enter Research Collaboration

Circio Holding ASA

10/02/2021 06:06

Feb 10 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX AND PAPYRUS THERAPEUTICS ENTER RESEARCH
COLLABORATION
TO DEVELOP NOVEL ONCOS VIRUSES WITH RECEPTOR TYROSINE KINASE
(RTK) INHIBITOR FUNCTIONALITY
    * TARGOVAX AND PAPYRUS THERAPEUTICS ENTER RESEARCH
COLLABORATION
TO DEVELOP NOVEL ONCOS VIRUSES WITH RECEPTOR TYROSINE KINASE
(RTK) INHIBITOR FUNCTIONALITY
    * PARTIES WILL EXPLORE FEASIBILITY AND EFFECT OF COMBINING
THEIR
RESPECTIVE ONCOLYTIC VIRUS AND RECEPTOR TYROSINE KINASE (RTK)
INHIBITOR TECHNOLOGIES
    * RETAINS RIGHT TO DEVELOP AND COMMERCIALIZE NOVEL DRUG
CANDIDATES
EMERGING FROM PRE-CLINICAL COLLABORATION

Source text for Eikon:  ID:nWkr3qSbkx 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))